Management of epistaxis in patients with ventricular assist device: a retrospective review

BACKGROUND: Patients with a ventricular assist device (VAD) are at risk for epistaxis due to the need for anticoagulation. Additionally, these patients develop acquired von Willebrand syndrome (AvWS) due to these devices. Management is complicated by the risk of thrombosis if anticoagulation is reve...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Clifford Scott, Abi-Hachem, Ralph, Jang, David Woojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090909/
https://www.ncbi.nlm.nih.gov/pubmed/30068378
http://dx.doi.org/10.1186/s40463-018-0295-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090909/
https://www.ncbi.nlm.nih.gov/pubmed/30068378
http://dx.doi.org/10.1186/s40463-018-0295-6

Ejemplares similares